Cancer News and Research

Latest Cancer News and Research

Health care reform will lead more people to seek cancer prevention and risk-reduction services

More people will likely seek cancer prevention and risk-reduction services as a result of health care reform, say experts at The University of Texas MD Anderson Cancer Center.

19 Oct 2010

Increased colorectal cancer screening in pre-Medicare population can reduce program costs

Investment in screening programs that target the pre-Medicare population, individuals aged between 50 and 64, is needed to reduce the costs of colorectal cancer in the Medicare program, according to the results of a new study, "Cost-Savings to Medicare from Increased Colorectal Cancer Screening in the Pre-Medicare Population," unveiled today at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas.

19 Oct 2010

ACG 75th Scientific Meeting to review advances in gastrointestinal research, treatment of digestive diseases

Many of the world's preeminent gastroenterologists will gather for the American College of Gastroenterology's (ACG) 75th Annual Scientific Meeting at the Henry B. Gonzalez Convention Center in San Antonio, Texas starting Monday October 18, 2010, to review the latest scientific advances in gastrointestinal research, treatment of digestive diseases and clinical practice management.

19 Oct 2010

Study suggests disparity in colorectal cancer demographics and outcomes between various races

The latest colorectal cancer research presented at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio this week strengthens the growing body of evidence that suggests significant disparity in colorectal cancer (CRC) demographics and outcomes between various races.

19 Oct 2010

'Sister' mitral cells may broadcast 2 distinct channels of information on odors to cortex

A team co-led by neuroscientists at Cold Spring Harbor Laboratory (CSHL) has shed light -- literally -- on circuitry underlying the olfactory system in mammals, giving us a new view of how that system may pull off some of its most amazing feats.

19 Oct 2010

Five Prime Therapeutics relocates into new drug discovery facility in South San Francisco

Five Prime Therapeutics, Inc., a leader in biologics, has relocated into its state-of-the-art drug discovery facility in South San Francisco. The new facility provides FivePrime with a two fold increase in square footage without significant incremental rental cost. The relocation includes an expanded laboratory facility for the Company to accelerate its innovative and proprietary protein therapeutic and antibody drug discovery platform.

19 Oct 2010

Cytheris initiates ORVACS Phase II clinical trial to study HIV infection

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of Phase II clinical trial of the company's investigative immunomodulatory agent, CYT107 (rhIL-7), in combination with two potent antiretroviral drugs represented by the integrase inhibitor raltegravir (ISENTRESS- Merck & Co.) and the CCR5 inhibitor, maraviroc (SELZENTRY- ViiV Healthcare).

19 Oct 2010

Study estimates demand for radiation therapy will increase by 22% over next decade

Between 2010 and 2020, the demand for radiation therapy will exceed the number of radiation oncologists practicing in the U.S. tenfold, which could profoundly affect the ability to provide patients with sufficient access to treatment, according to new research from The University of Texas MD Anderson Cancer Center.

19 Oct 2010

Amgen to review study results of ESA in chronic renal failure patients with FDA and CRDAC

Amgen will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal failure (CRF) patients at today's meeting of the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC).

19 Oct 2010

An overview on American College of Gastroenterology's Annual Scientific meeting

The association between obesity and gastrointestinal-related cancers and coronary artery disease; the link between an overweight or obese body mass index and the severity of Crohn's disease; and whether inflammatory bowel disease is an independent risk factor for coronary artery disease, were among the highlights of new research that was presented this week at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio.

19 Oct 2010

Tips to improve cellular prostate health

Prostate cancer is one of the most common cancers in America and may lead to more than 32,000 deaths this year. Medical Doctor and cancer expert, Dr. Isaac Eliaz announces breakthrough research and essential recommendations for the prevention and treatment of prostate cancer.

19 Oct 2010

Fatalism may prevent Latinas from using cancer screening services

Fatalism may prevent women from Latin American descent Latinas from using cancer screening services, according to Karla Espinosa de los Monteros and Dr. Linda Gallo from San Diego State University in the US. Their review shows that women who are pessimistic about preventive health practices and disease outcomes are less likely to have been screened for cervical, breast and colorectal cancer. The research is published online in Springer's International Journal of Behavioral Medicine.

19 Oct 2010

Many skin cancer patients unaware of being diagnosed with melanoma or nonmelanoma cancer

Socioeconomic factors such as a lower level of education and lack of health insurance may impact individuals' knowledge of the type of skin cancer with which they are diagnosed. As a result, these individuals may have a poor sense of the measures they need to take to reduce the risk of future skin cancers.

19 Oct 2010

BD, Walter and Eliza Hall Institute collaborate to commercialize antibodies

The Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, has entered a collaboration with New Jersey based medical technology company BD to evaluate and potentially develop for research and diagnostic use some of the institute's reagents.

19 Oct 2010

DOD awards grant to develop ‘lab-on-a-chip’ device for monitoring patients with severe brain injury

The US Department of Defense (DOD) has awarded a $5 million grant to The Feinstein Institute for Medical Research and the University of Cincinnati to further develop a "lab-on-a-chip" device used for monitoring patients suffering from severe brain injury.

19 Oct 2010

Positive results from Diamyd Medical's NP2 Enkephalin Phase I trial for chronic pain

Substantial and sustained reduction in pain scores were reported in the middle and high dose cohorts of Diamyd Medical's Phase I, open-label, dose escalation trial investigating NP2 Enkephalin as a potential therapy for chronic pain. No treatment related Serious Adverse Events have been observed in the study to date.

19 Oct 2010

Novartis announces six-year data of Reclast injection for postmenopausal women with osteoporosis

Novartis announced today that new six-year data reinforce the long-term efficacy and safety profile of once-yearly Reclast (zoledronic acid) injection in postmenopausal women with osteoporosis.The study of more than 1,200 women was presented this weekend at the annual meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, ON, Canada.

19 Oct 2010

MPI of Biochemistry and GSK collaborate in development of new drugs for type 2 diabetes

The recently signed cooperation agreement between the MPI of Biochemistry and GSK pursues the objective of developing innovative new drugs. The joint research and development work is based on the research findings of Axel Ullrich, Director at the MPI of Biochemistry.

19 Oct 2010

Long-term use of statins reduces colorectal cancer risk

A systematic review of the medical literature supports the hypothesis that statins, cholesterol-lowering drugs used to prevent cardiac problems, are associated with reduced risk of colon and rectal cancers.

19 Oct 2010

Study suggests epoD; microtubule-stabilizing drugs may treat neurodegenerative diseases

Finding a drug that can cross the blood-brain barrier is the bane of drug development for Alzheimer's disease and other neurological disorders of the brain. A new Penn study, published this week in the Journal of Neuroscience, has found and tested in an animal model of Alzheimer's disease a class of drug that is able to enter the brain, where it stabilizes degenerating neurons and improves memory and learning.

19 Oct 2010

Cancer News and Research

Latest Cancer News and Research

Health care reform will lead more people to seek cancer prevention and risk-reduction services

Increased colorectal cancer screening in pre-Medicare population can reduce program costs

ACG 75th Scientific Meeting to review advances in gastrointestinal research, treatment of digestive diseases

Study suggests disparity in colorectal cancer demographics and outcomes between various races

'Sister' mitral cells may broadcast 2 distinct channels of information on odors to cortex

Five Prime Therapeutics relocates into new drug discovery facility in South San Francisco

Cytheris initiates ORVACS Phase II clinical trial to study HIV infection

Study estimates demand for radiation therapy will increase by 22% over next decade

Amgen to review study results of ESA in chronic renal failure patients with FDA and CRDAC

An overview on American College of Gastroenterology's Annual Scientific meeting

Tips to improve cellular prostate health

Fatalism may prevent Latinas from using cancer screening services

Many skin cancer patients unaware of being diagnosed with melanoma or nonmelanoma cancer

BD, Walter and Eliza Hall Institute collaborate to commercialize antibodies

DOD awards grant to develop ‘lab-on-a-chip’ device for monitoring patients with severe brain injury

Positive results from Diamyd Medical's NP2 Enkephalin Phase I trial for chronic pain

Novartis announces six-year data of Reclast injection for postmenopausal women with osteoporosis

MPI of Biochemistry and GSK collaborate in development of new drugs for type 2 diabetes

Long-term use of statins reduces colorectal cancer risk

Study suggests epoD; microtubule-stabilizing drugs may treat neurodegenerative diseases

Cancer Research - Second Edition eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in